The Latest Breaking News from HIV

Gilead stock sprinted to a profit-taking zone Thursday after Gilead Sciences rode its Covid treatment to another beat and raise.

The far-reaching impact of certain viruses on the body can make cells grow out of control, causing cancer.

The World Health Organization’s 2024 Global Tuberculosis report reveals a sobering reality. Formidable challenges remain in the fight against the world’s most infectious disease: persistent poverty in high burden countries; increased rates of infection among vulnerable populations; the inability to find and treat all missing cases; and funding shortfalls.

Clients of now closed Fresh Cosmetic Clinic warned to get tested after possible exposure to blood-borne viruses such as hepatitis B, hepatitis C or HIV

The drugmaker said sales of Arexvy fell sharply in the third quarter, but cancer and HIV treatments saw a stronger performance.

There are many myths about breast cancer, particularly in Africa with its rich diversity of people, different genetic backgrounds and ancestral histories.

Recent study supports safe kidney transplants between HIV-positive individuals, potentially reducing wait times and improving organ access.

A new study found people with HIV can safely receive donated kidneys from deceased donors with the virus

The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To capitalize on the industry’s expansion, it could be wise to invest in fundamentally sound biotech stocks, Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), and Biogen (BIIB), which have the potential to revolutionize medicine. Read…

On Call, Anthony Fauci's new memoir, can't disguise the damage caused by his COVID-19 policies.

A new drug to prevent HIV infection is showing hugely promising results in clinical trials when injected every six months.